Inhibition of polymorphonuclear leukocyte-mediated graft damage synergizes with short-term costimulatory blockade to prevent cardiac allograft rejection

Circulation

Volumn 112, Issue 3, 2005, Pages 320-331

  El Sawy, Tarek ^a,d   Belperio, John A ^b   Strieter, Robert M ^b   Remick, Daniel G ^c   Fairchild, Robert L ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Endothelium; Immunology; Inflammation; Lymphocytes; Transplantation

Indexed keywords

ALLOANTIGEN; CD40 LIGAND MONOCLONAL ANTIBODY; CHEMOKINE; CHEMOKINE RECEPTOR CXCR2; CXCL1 CHEMOKINE; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ALLOGRAFT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC GRAFT REJECTION; CONTROLLED STUDY; GRAFT DYSFUNCTION; GRAFT SURVIVAL; HEART MUSCLE REPERFUSION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE DEPLETION; LYMPHOCYTIC INFILTRATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; ENDOTHELIAL CELLS; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOCONJUGATES; IMMUNOLOGIC MEMORY; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEUTROPHIL INFILTRATION; NEUTROPHILS; RECEPTORS, INTERLEUKIN-8B; TRANSPLANTATION, HOMOLOGOUS;

EID: 22544485410     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.104.516708     Document Type: Article

References (37)

1. Rosenberg AS, Singer A. Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. Annu Rev Immunol. 1992;10:333-358.
2. Larsen CP, Morris PJ, Austyn JM. Migration of dendritic leukocytes from cardiac allografts into host spleens: a novel pathway for initiation of rejection. J Exp Med. 1990;171:307-314.
3. Hall BM. Cells mediating allograft rejection. Transplantation. 1991;51:1141-1151.
4. El-Sawy T, Fahmy NM, Fairchild RL. Chemokines: directing leukocyte infiltration into allografts. Curr Opin Immunol 2002;14:562-568.
5. Myers BD, Ross J, Newton L, Luetscher J, Perlroth M. Cyclosporine- associated chronic nephropathy. N Engl J Med. 1984;311:699-705.
6. Perm I. Malignant melanoma in organ allograft recipients. Transplantation. 1996;61:274-278.
7. Sperling AI, Bluestone JA. The complexities of T-cell co-stimulation: CD28 and beyond. Immunol Rev. 1996;153:155-182.
8. Bretscher P, Conn M. A theory of self-nonself discrimination. Science. 1970;169:1042-1049.
9. Sayegh MH, Turka LA. The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med. 1998;338:1813-1821.
10. Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R. Tucker-Burden C, Cho HR, Aruffo A, Hollenbaugh D, Linsley PS, Winn KJ, Pearson TC. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature. 1996;381:434-438.
11. Wang CY, Mazer SP, Minamoto K, Takuma S, Hotntna S, Yellin M. Chess L, Fard A, Kalled SL, Oz MC, Pinsky DJ. Suppression of murine cardiac allograft arteriopathy by long-term blockade of CD40-CD154 interactions. Circulation. 2002;105:1609-1614.
12. Shimizu K, Schonbeck U, Mach F, Libby P, Mitchell RN. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis. J Immunol. 2000;165:3506-3518.
13. Laskowski I, Pratschke J, Wilhelm MJ, Gasser M, Tilney NL. Molecular and cellular events associated with ischemia/reperfusion injury. Ann Transplant. 2000;5:29-35.
14. Tilney NL, Guttmann RD, Effects of initial ischemia/reperfusion injury on the transplanted kidney. Transplantation. 1997;64:945-947.
15. Bergese SD, Huang EH, Pelletier RP, Widmer MB, Ferguson RM, Orosz CG. Regulation of endothelial VCAM-1 expression in murine cardiac grafts: expression of allograft endothelial VCAM-1 can be manipulated with antagonist of IFN-α or IL-4 and is not required for allograft rejection. Am J Pathol. 1995;147:166-175.
16. Fuggle SV, Sanderson JB, Gray DW, Richardson A, Morris PJ. Variation in expression of endothelial adhesion molecules in pretransplant and transplanted kidneys: correlation with intragraft events. Transplantation. 1993;55:117-123.
17. Rabb H, O'Meara YM, Madema P, Coleman P, Brady HR. Leukocytes, cell adhesion molecules and ischemie acute renal failure. Kidney Int. 1997;51:1463-1468.
18. Jaeschke H, Farhood A, Smith CW. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J. 1990;4:3355-3359.
19. Corry RJ, Winn UJ, Russell PS. Primarily vascularized allografts of hearts in mice: the role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation. 1973;16:343-350.
20. Belperio JA, Keane MP, Burdick MD, Londhe V, Xue YY, Li K, Phillips RJ, Strieter RM. Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. J Clin Invest. 2002;110:1703-1716.
21. Call DR, Nemzek JA, Ebong SJ, Bolgos GR, Newcomb DE, Wollenberg GK, Remick DG. Differential local and systemic regulation of the murine chemokines KC and MIP2. Shock. 2001;15:278-284.
22. Call DR, Nemzek JA, Ebong SJ, Bolgos GL, Newcomb DE, Remick DG. Ratio of local to systemic chemokine concentrations regulates neutrophil recruitment. Am J Pathol 2001;158:715-721.
23. Miura M, Fu X, Zhang QW, Remick DG, Fairchild RL. Neutralization of Gro alpha and macrophage inflammatory protein-2 attenuates renal ischemia/reperfusion injury. Am J Pathol. 2001;159:2137-2145.
24. Gorbachev AV, Heeger PS, Fairchild RL. CD4+ and CD8+ T cell priming for contact hypersensitivity occurs independently of CD40-CD154 interactions. J Immunol. 2001;166:2323-2332.
25. Morita K, Miura M, Paolone DR, Engeman TM, Kapoor A, Remick DG, Fairchild RL. Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection. J Immunol. 2001;167:2979-2984.
26. Murphy PM, Baggiolini M, Charo IF, Hebert CA, Horuk R, Matsushima K, Miller LH, Oppenheim JJ, Power CA. International union of pharmacology, XXII: nomenclature for chemokine receptors. Pharmacol Rev. 2000;52:145-176.
27. Rollins BJ. Chemokines Blood. 1997;90:909-928.
28. Jones SP, Trocha SD, Strange MB, Granger DN, Kevil CG, Bullard DC, Lefer DJ. Leukocyte and endothelial cell adhesion molecules in a chronic murine model of myocardial reperfusion injury. Am J Physiol Heart Circ Physiol. 2000;279:H2196-H2201.
29. Kaminski KA, Bonda TA, Korecki J, Musial WJ. Oxidative stress and neutrophil activation: the two keystones of ischemia/reperfusion injury. Int J Cardiol. 2002;86:41-59.
30. Miura M, Morita K, Kobayashi H, Hamilton TA, Burdick MD, Strieter RM, Fairchild RL. Monokine induced by IFN-γ is a dominant factor directing T cells into murine cardiac allografts during acute rejection. J Immunol. 2001;167:3494-3504.
31. Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med. 1999;5:1249-1255.
32. Bingaman AW, Ha J, Waitze SY, Durham MM, Cho HR, Tucker-Burden C, Hendrix R, Cowan SR, Pearson TC, Larsen CP. Vigorous allograft rejection in the absence of danger. J Immunol. 2000;164:3065-3071.
33. Larsen CP, Pearson TC. The CD40 pathway in allograft rejection, acceptance, and tolerance. Curr Opin Immunol. 1997;9:641-647.
34. Spitzer TR, Delmonico F, Tolkoff-Rubin N, McAfee S, Sackstein R, Saidman S, Colby C, Sykes M, Sachs DH, Cosimi AB. Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation. 1999;68:480-484.
35. El-Sawy T, Miura M, Fairchild R. Early T cell response to allografts occurring prior to alloantigen priming up-regulates innate-mediated inflammation and graft necrosis. Am J Pathol. 2004;165:147-I57.
36. Selin LK, Cornberg M, Brehm MA, Kim SK, Calcagno C, Ghersi D, Puzone R, Celada F, Welsh RM. CDS memory T cells: cross-reactivity and heterologous immunity. Semin Immunol. 2004;16:335-347.
37. Adams AB, Williams MA, Jones TR, Shirasugi N, Durham MM, Kaech SM, Wherry EJ, Onami T, Lanier JG, Kokko KE, Pearson TC, Ahmed R, Larsen CP. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest. 2003;111:1887-1895.